Leadsynbio is selected for the 2025 China Potential Unicorn Enterprises list Leveragingcutting-edge innovation and outstanding commercialization capabilities in the field of synthetic biology, Leadsynbio was successfully selectedfor the 2025 China Potential Unicorn Enterprises list, demonstrating ourstrong growthpotentialand core competitiveness.

Market | Leadsynbio Showcases 25-Hydroxyvitamin D₃ at Vitamin Summit, Advancing Industry Sustainability On December 4th,Leadsynbio actively participated in the 2025 China Vitamin Industrial Summit, gainingvaluable industry insights and engagingin in-depth exchanges with numerous partners. We have been monitoring the evolution of the competitive landscape and exploring breakthrough strategies for the new era.Looking ahead, Leadsynbio is committed to driving innovation and reshaping the industry landscape with high-quality and sustainable ingredients.

Market | Forging Ahead! Leadsynbio Returns to the 93rd API China, Showcasing Tech Prowess On November 12, at the 93rd API China in Chongqing, we showcased a range of our bio-manufactured ingredients. This builds on our October showcase at CPHI Frankfurt 2025, underscoring our focused strategy for global market growth and commercial execution. We highlighted our proprieta......

Leadsynbio Makes Its Mark at CPHI Frankfurt 2025, Highlighting Innovation and Integrated Capabilities Frankfurt, Germany – From October 28 to 30, we presented our capabilities at CPHI Frankfurt, the world's leading pharmaceutical industry exhibition, at our booth H94 in Hall 11.1. We showcased our latest advancements in synthetic biology, commercial-scale production, and global operati......